← All trials
NCT05168774
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 3, 2022
- Primary completion
- Jun 30, 2023
- Completion date
- Jun 30, 2024
- First posted
- Dec 23, 2021
- Last posted
- Jul 28, 2022
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PennsylvaniaLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- University of PennsylvaniaReponsible party - principal investigator
- Stealth BioTherapeutics Inc.Collaborator
- University of PennsylvaniaOfficial
- University of PennsylvaniaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.